What can narcolepsy teach us about hypocretin and dementia?

Abstract

Sleep and circadian disturbances are associated with cognitive decline and dementia. Narcolepsy type 1 (NT1), characterized by severe sleep-wake disruption and loss of hypocretin, would therefore be expected to predispose individuals to premature brain aging. Yet available biomarker and neuroimaging findings do not consistently support this possibility, raising questions about the role of hypocretin in mechanisms linking sleep to neurodegeneration. Beyond maintaining wakefulness, hypocretin interacts with inflammatory circuits, metabolic regulation, synaptic plasticity, amyloid processing, and circadian organization. Moreover, wake continuity and neuronal activity during this state may be relevant to the production and release of proteins implicated in neurodegeneration. The coexistence of profound sleep-wake abnormalities and an inconsistent neurodegenerative biomarker profile makes NT1 a unique human condition for investigating these relationships. Understanding this apparent paradox may provide new perspectives on how hypocretin, sleep-wake dynamics, neuronal signaling, and circadian biology relate to long-term brain health and dementia.